Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

O. Arpí · SciRah

Researcher profile · Semantic Scholar

O. Arpí

Share profile

O. Arpí — researcher profile on SciRah

h-index: 19
Works: 39
Citations: 1,028

Most-cited papers

A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples
A. Esteve-Codina, O. Arpí, M. Martínez-García, E. Pineda +14 more
2017PLoS ONE125 citations Open access
Semantic Scholar
Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer
I. Cañadas, F. Rojo, Á. Taus, O. Arpí +11 more
2013Clinical Cancer Research124 citations
Semantic Scholar
Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer
MohammadA Sabbaghi, G. Gil-Gómez, Cristina Guardia, S. Servitja +20 more
2017Clinical Cancer Research96 citations Open access
Semantic Scholar
Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer
M. Hardy-Werbin, P. Rocha, O. Arpí, Á. Taus +12 more
2019Oncoimmunology69 citations Open access
Semantic Scholar
The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer
F. J. Sánchez-Martín, B. Bellosillo, Mariona Gelabert-Baldrich, A. Dalmases +18 more
2016Clinical Cancer Research65 citations Open access
Semantic Scholar
MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines
E. Arriola, I. Cañadas, M. Arumí-Uría, M. Dómine +11 more
2011British Journal of Cancer61 citations Open access
Semantic Scholar
Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines.
S. Zazo, Paula González-Alonso, E. Martı́n-Aparicio, C. Chamizo +8 more
2016American Journal of Cancer Research48 citations
Semantic Scholar
HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer
A. Sampera, F. J. Sánchez-Martín, O. Arpí, L. Visa +12 more
2019Molecular Cancer Therapeutics45 citations
Semantic Scholar
Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer
A. Dalmases, I. González, S. Menéndez, O. Arpí +13 more
2013OncoTarget42 citations Open access
Semantic Scholar
High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients
I. Cañadas, Á. Taus, I. González, X. Villanueva +12 more
2014OncoTarget38 citations Open access
Semantic Scholar
NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer
Sara Santana-Hernández, Jesús Suarez-Olmos, S. Servitja, P. Berenguer-Molins +17 more
2024Journal of experimental & clinical cancer research : CR37 citations Open access
Semantic Scholar
High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer
A. Muntasell, S. Servitja, Mariona Cabo, B. Bermejo +20 more
2019Cancer immunology research33 citations Open access
Semantic Scholar
Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer Models
A. Hernández-Prat, A. Rodríguez-Vida, N. Juanpere-Rodero, O. Arpí +9 more
2019Molecular Cancer Research31 citations Open access
Semantic Scholar
This is a repository copy of Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab
O. Arpí, Á. Taus, P. Rocha, D. Joseph-Pietras +8 more
201831 citations
Semantic Scholar
Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer.
J. Garcia-Parra, A. Dalmases, B. Morancho, O. Arpí +14 more
2014European Journal of Cancer29 citations
Semantic Scholar
The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer
Paula González-Alonso, S. Zazo, E. Martı́n-Aparicio, M. Luque +16 more
2020Cancers27 citations Open access
Semantic Scholar
Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer
S. Zazo, Paula González-Alonso, E. Martı́n-Aparicio, C. Chamizo +14 more
2020Molecular Cancer Therapeutics26 citations
Semantic Scholar
Angiopoietin-2 is a negative prognostic marker in small cell lung cancer.
I. Cañadas, Á. Taus, X. Villanueva, O. Arpí +8 more
2015Lung Cancer20 citations
Semantic Scholar
The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer
L. M. Boll, J. Perera-Bel, A. Rodríguez-Vida, O. Arpí +7 more
2023Scientific Reports19 citations Open access
Semantic Scholar
Gene Expression Profiling in True Interval Breast Cancer Reveals Overactivation of the mTOR Signaling Pathway
F. Rojo, L. Domingo, M. Sala, S. Zazo +13 more
2013Cancer Epidemiology, Biomarkers and Prevention15 citations
Semantic Scholar
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy
C. Carrato, F. Alameda, A. Esteve-Codina, E. Pineda +26 more
2020Clinical Cancer Research10 citations Open access
Semantic Scholar
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP–negative Glioblastoma
A. Esteve-Codina, F. Alameda, C. Carrato, E. Pineda +27 more
2020Clinical Cancer Research10 citations
Semantic Scholar
CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer
M. Luque, I. Cristóbal, Marta Sanz-Álvarez, Andrea Santos +8 more
2022Journal of Clinical Medicine9 citations Open access
Semantic Scholar
PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects
R. Rincón, I. Cristóbal, S. Zazo, O. Arpí +9 more
2015OncoTarget8 citations Open access
Semantic Scholar
Glioblastoma gene expression subtypes and correlation with clinical, molecular and immunohistochemical characteristics in a homogenously treated cohort: GLIOCAT project.
E. Pineda, A. Esteve-Codina, M. Martínez-García, F. Alameda +16 more
2019Journal of Clinical Oncology6 citations
Semantic Scholar
Targeting the PI3K/AKT/mTOR pathway with MLN0128 (mTORC1/2 inh) and MLN1117 (PI3K alpha inh) in bladder cancer: Rational for its testing in clinical trials.
Alejandro Martínez, A. Hernandez, O. Arpí, S. Menéndez +11 more
20152 citations
Semantic Scholar
P1.15-001 Ipilimumab Increases Th1/Th2 and Inflammatory Cytokines Counteracting Chemotherapy Effects in Small Cell Lung Cancer
M. Hardy-Werbin, P. Rocha, O. Arpí, Á. Taus +5 more
20171 citations Open access
Semantic Scholar
Identification of molecular mechanisms of acquired resistance to trastuzumab in gastric cancer
A. Sampera, Mariona Gelabert-Baldrich, F. J. Sánchez-Martín, A. Dalmases +6 more
20161 citations
Semantic Scholar
Abstract 2149: The anti-EGFR antibody mixture Sym004 overcomes acquired resistance to cetuximab in colorectal cancer
F. J. Sánchez-Martín, A. Dalmases, B. Bellosillo, G. Argilés +17 more
20161 citations
Semantic Scholar
Gene expression profiling of glioblastoma (GBM) in an homogeneous treated population: Correlation with immunohistochemistry, radiology, clinical outcome, and response to therapy—A multicenter study from the GLIOCAT group, Marato TV3 2012, project 665/c/2013.
C. Balañà, F. Alameda, N. de la Iglesia, J. Capellades +16 more
20161 citations
Semantic Scholar
MGMT methylated (Met) patients (p) with glioblastoma (GBM) have a better prognosis with an earlier response (ER) than those who have a late response or pseudoprogression (LR/PsP). Results of the Gliocat study
A. Estival, E. Pineda, M. Martínez-García, J. Marruecos +16 more
20161 citations Open access
Semantic Scholar
Is IDO1 an adequate target for treatment in glioblastoma?
Christian Andre Mariño Siancas, Ainhoa Hernandez Gonzalez, M. Domènech, A. Esteve-Codina +14 more
2022Journal of Clinical Oncology0 citations
Semantic Scholar
Gene fusions in glioblastoma: Results of Gliocat project.
Ainhoa Hernandez Gonzalez, A. Esteve-Codina, C. Carrato, A. Muñoz +13 more
20210 citations
Semantic Scholar
Higher PD-L1 expression correlates with lymphocyte infiltration in early non-small cell lung cancer.
P. Rocha, M. Rodrigo, L. Moliner, M. Hardy-Werbin +11 more
2019Annals of Oncology0 citations Open access
Semantic Scholar
Abstract LB-143: Th1/Th2 and inflammatory cytokines as biomarkers of response to ipilimumab in small cell lung cancer (SCLC) patients
Max Hardy-Werbin, Pedro Rocha, O. Arpí, Á. Taus +6 more
2018Clinical research0 citations
Semantic Scholar
330PDGalectin-1 (Gal-1) expression as a prognostic factor in a homogenous cohort of glioblastoma (GB) (Gliocat study)
N. V. Quintela, N. Bosch, C. Balañà, F. Alameda +16 more
20170 citations Open access
Semantic Scholar
Targeting the PI3K/AKT/mTOR pathway with a dual mTORC1/2 inhibitor in bladder cancer. Rationale for its testing in clinical trials
A. Hernández-Prat, Alejandro Martínez, O. Arpí, S. Menéndez +6 more
20160 citations
Semantic Scholar
Sym004 to circumvent resistance to cetuximab driven by emergence of EGFR extracellular mutations in colorectal cancer.
C. Montagut, I. Cañadas, E. Gavilan, O. Arpí +5 more
20150 citations
Semantic Scholar
Preclinical in vitro and in vivo evaluation of antitumor activity of poly (ADP-ribose) polymerase inhibition and trastuzumab combined therapy in HER2-overexpressing breast cancer.
I. Tusquets, J. Garcia-Parra, A. Dalmases, B. Morancho +14 more
20140 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Rovira×27
Invite
A. Rovira — researcher profile on SciRah
J. Albanell×25
Invite
J. Albanell — researcher profile on SciRah
F. Rojo×15
Invite
F. Rojo — researcher profile on SciRah
S. Menéndez×15
Invite
S. Menéndez — researcher profile on SciRah

×10

Invite

S. Zazo — researcher profile on SciRah

Invite

P. Eroles — researcher profile on SciRah

M. Martínez-García×9

Invite

M. Martínez-García — researcher profile on SciRah

Invite

E. Pineda — researcher profile on SciRah

Invite

C. Carrato — researcher profile on SciRah

Invite

C. Balañà — researcher profile on SciRah

Invite

F. Alameda — researcher profile on SciRah

Invite

Á. Taus — researcher profile on SciRah